KR102631920B1 - A food composition comprising Neomysis awatschensis oil for anti-obesity - Google Patents

A food composition comprising Neomysis awatschensis oil for anti-obesity Download PDF

Info

Publication number
KR102631920B1
KR102631920B1 KR1020210057667A KR20210057667A KR102631920B1 KR 102631920 B1 KR102631920 B1 KR 102631920B1 KR 1020210057667 A KR1020210057667 A KR 1020210057667A KR 20210057667 A KR20210057667 A KR 20210057667A KR 102631920 B1 KR102631920 B1 KR 102631920B1
Authority
KR
South Korea
Prior art keywords
oil
obesity
weight
group
insect
Prior art date
Application number
KR1020210057667A
Other languages
Korean (ko)
Other versions
KR20220150551A (en
Inventor
오창근
임재용
오정자
이학용
박영미
신동엽
Original Assignee
오천영어조합법인
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오천영어조합법인 filed Critical 오천영어조합법인
Priority to KR1020210057667A priority Critical patent/KR102631920B1/en
Publication of KR20220150551A publication Critical patent/KR20220150551A/en
Application granted granted Critical
Publication of KR102631920B1 publication Critical patent/KR102631920B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/02Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/40Shell-fish
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332Promoters of weight control and weight loss
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/204Animal extracts
    • A23V2250/2042Marine animal, fish extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/34Membrane process
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/50Concentrating, enriching or enhancing in functional factors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

곤쟁이의 신규 용도로서 항비만을 위한 식품 조성물로 활용하는 방안이 제시된다. 본 발명은 곤쟁이 오일을 포함하는 항비만용 식품 조성물을 제공한다.As a new use of the insect, a method of using it as a food composition for anti-obesity is proposed. The present invention provides a food composition for anti-obesity containing chamomile oil.

Description

곤쟁이 오일을 포함하는 항비만용 식품 조성물{A food composition comprising Neomysis awatschensis oil for anti-obesity}Food composition for anti-obesity comprising Neomysis awatschensis oil for anti-obesity}

본 발명은 항비만용 식품 조성물에 관한 것으로, 보다 상세하게는 곤쟁이 오일을 포함하는 항비만용 식품 조성물에 관한 것이다.The present invention relates to a food composition for anti-obesity, and more specifically, to a food composition for anti-obesity containing dandelion oil.

경제발전과 더불어 우리나라 생활방식은 서구 선진국 형태로 발전함에 따라 식생활의 변화 및 육체적인 활동이 감소되면서, 신체 내의 체지방이 증가되고 대사의 불균형으로 비만 인구가 증가하고 있으며, 이로 인해 당뇨병, 고지혈증, 혈전장애 등 심혈관계 질환이 복합적으로 나타나는 이른바 대사증후군의 발생빈도가 지속적으로 높아 지고 있다(Lee SJ, Park JY, Nam CM, Jee SH. 2008. The prevalence estimation of metabolic syndrome and it's related factors based on data from general health medical examination: a multi-center study. J Korean Soc Health Information Health Statistics 33: 119-133; Frohlich J, Lear SA. 2002. Old and new risk factors for atherosclerosis and development of treatment recommendations. Clin Exp Pharmacol Physiol 29: 838-842).Along with economic development, our country's lifestyle has developed into that of advanced Western countries. As dietary habits change and physical activity decreases, body fat in the body increases and the number of obese people increases due to metabolic imbalance, resulting in diabetes, hyperlipidemia, and blood clots. The incidence of the so-called metabolic syndrome, which is a combination of cardiovascular diseases such as disability, is continuously increasing (Lee SJ, Park JY, Nam CM, Jee SH. 2008. The prevalence estimation of metabolic syndrome and it's related factors based on data from general health medical examination: a multi-center study. J Korean Soc Health Information Health Statistics 33: 119-133; Frohlich J, Lear SA. 2002. Old and new risk factors for atherosclerosis and development of treatment recommendations. Clin Exp Pharmacol Physiol 29 : 838-842).

비만은 한 가지 원인으로 발생하는 질병이 아니라, 유전적, 환경적, 사회적 요인들에 의해 복합적으로 나타나는 증후군으로, 에너지의 과다 섭취 후 체내 대사활동에서 소비되지 못하고 지방조직에 중성지방으로 축적되어 발 생된다(Chua, S.C.Jr. Monogenic models of obesity. Behav Genet. 27: 277-284, 1997). 또한, 비만에서 보이 는 혈중 지방산(fatty acid) 농도와 복부 비만의 증가는 고지혈증과 제 2형 당뇨병의 흔한 증상으로, 자유지방 산의 증가는 심실 비대를 야기하고(DeFronzo, R.A, Ferrannini, E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14(3): 173-194, 1991), 복부 지방 축적은 인슐린 저항성의 유발에 밀접한 연관성이 있음이 보고되었고(Tamori, Y., Kasuga, M. Obesity and insulin resistance. Nippon Rinsho. 67(2):236-244, 2009), 이로 인하여 고혈압, 동맥경화증, 당뇨병, 고지혈증 등의 생활습관병을 야기하는 원인이 되거나 건강을 악화시키는 요인이 되고 있다.Obesity is not a disease caused by a single cause, but a syndrome that is caused by a combination of genetic, environmental, and social factors. After excessive intake of energy, it is not consumed in the body's metabolic activities and is accumulated as neutral fat in adipose tissue. (Chua, S.C.Jr. Monogenic models of obesity. Behav Genet. 27: 277-284, 1997). In addition, increased blood fatty acid concentration and abdominal obesity seen in obesity are common symptoms of hyperlipidemia and type 2 diabetes, and increased free fatty acid causes ventricular hypertrophy (DeFronzo, R.A, Ferrannini, E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14(3): 173-194, 1991), abdominal fat accumulation is closely related to causing insulin resistance. It has been reported (Tamori, Y., Kasuga, M. Obesity and insulin resistance. Nippon Rinsho. 67(2):236-244, 2009), which causes lifestyle diseases such as hypertension, arteriosclerosis, diabetes, and hyperlipidemia. This is becoming a factor that worsens health.

곤쟁이(Neomysis awatschensis)는 곤쟁이과에 속하는 갑각류로, 대부분 바다에 서식하며 작은 새우처럼 생겼다. 몸길이는 1 내지 2 cm 정도이고, 여덟 쌍의 가슴다리가 있고 가슴다리의 기부에 노출된 아가미를 가진 점이 새우와 다르다. 한국 서해에서 많이 잡히는데, 소금에 절인 것을 곤쟁이젓이라 하여 먹으며, 많이 잡히는 곳에서는 사료 및 거름으로도 쓰인다. 우리나라 연안에 서식하는 20여 종의 곤쟁이는 몸길이 약 1 cm이며 '자하(紫蝦)'라고도 한다.Neomysis awatschensis (Neomysis awatschensis) is a crustacean belonging to the Awatsidae family. It lives mostly in the sea and looks like a small shrimp. The body length is about 1 to 2 cm, and it differs from shrimp in that it has eight pairs of pectoral legs and has gills exposed at the base of the pectoral legs. It is caught in large quantities in the West Sea of Korea, and when pickled in salt, it is eaten as gonjaengijeot, and in places where it is caught in large quantities, it is also used as feed and fertilizer. There are about 20 species of gophers that live along the coast of Korea, with a body length of about 1 cm, and are also called 'jaha (紫蝦)'.

그러나 아직까지 곤쟁이를 항비만을 위한 식품 조성물에 활용하고자 하는 사례는 보고되지 않고 있다.However, there have been no reported cases of using bugs in food compositions for anti-obesity yet.

본 발명에서는 곤쟁이의 신규 용도로서 항비만을 위한 식품 조성물로 활용하는 방안을 제시하고자 한다.In the present invention, we would like to propose a new use of gnats as a food composition for anti-obesity.

상기 과제를 해결하기 위한 일 양태로서 본 발명은, 곤쟁이 오일을 포함하는 항비만용 식품 조성물을 제공한다.As an aspect for solving the above problems, the present invention provides a food composition for anti-obesity containing insect oil.

또한 상기 곤쟁이 오일은 인지질 함량이 60 내지 70 중량%인 것을 특징으로 하는 항비만용 식품 조성물을 제공한다.In addition, the insect oil provides a food composition for anti-obesity, characterized in that the phospholipid content is 60 to 70% by weight.

상기 과제를 해결하기 위한 다른 양태로서 본 발명은, (a) 건조된 곤쟁이에 90 내지 100 %(v/v)의 주정을 10 내지 20배수 투입하여 추출하는 단계; (b) 상기 (a) 단계의 추출물을 1차 여과 후 40 내지 60℃에서 1차 감압농축하는 단계; 및 (c) 상기 (b) 단계의 농축물을 2차 여과 후 50 내지 100℃에서 2차 감압농축하여 점도 700 내지 1,000 cPs의 오일을 제조하는 단계;를 포함하는 항비만용 곤쟁이 오일 제조방법을 제공한다.As another aspect for solving the above problem, the present invention includes the steps of (a) adding 10 to 20 times 90 to 100% (v/v) of alcohol to dried ragweed and extracting it; (b) first filtering the extract of step (a) and then first concentrating it under reduced pressure at 40 to 60°C; and (c) secondary filtration of the concentrate from step (b) and secondary concentration under reduced pressure at 50 to 100°C to produce oil with a viscosity of 700 to 1,000 cPs. to provide.

본 발명에 따르면, 곤쟁이를 이용한 식품 조성물의 신규 용도로서 곤쟁이 오일을 포함하는 항비만용 식품 조성물과, 곤쟁이의 항비만 효능 극대화를 위한 곤쟁이 오일을 제조하는 방법을 제공할 수 있다.According to the present invention, it is possible to provide an anti-obesity food composition containing chamomile oil as a new use of a food composition using chamomile, and a method for producing chamomile oil to maximize the anti-obesity effect of chamomile.

도 1에 본 발명의 시험예에서 곤쟁이 원물(a), 열풍건조물(b), 추출물(c), 1차 농축물(d), 2차 농축물(e) 및 곤쟁이 오일(f)을 나타낸 사진이다.
도 2는 동물시험에 사용된 시험물질로서 (a) 곤쟁이 오일 및 (b) 가르시니아를 나타낸 사진이다.
도 3은 곤쟁이 오일이 고지방식이에 의한 비만 동물모델의 주간 체중에 미치는 영향을 분석한 결과를 나타낸 그래프이다.
도 4는 곤쟁이 오일이 고지방식이에 의한 비만 동물모델의 주간 식이 및 음수 섭취량에 미치는 영향을 분석한 결과를 나타낸 그래프이다.
도 5는 곤쟁이 오일이 비만 동물모델의 조직 중량에 미치는 영향을 분석한 결과를 나타낸 그래프이다.
도 6은 곤쟁이 오일이 비만 동물모델의 T-Chol, TG, LDL, HDL 농도에 미치는 영향을 분석한 결과를 나타낸 그래프이다.
도 7은 곤쟁이 오일이 비만 동물모델의 혈청 Leptin 농도에 미치는 영향을 분석한 결과를 나타낸 그래프이다.
Figure 1 is a photograph showing the raw material (a), hot air dried product (b), extract (c), primary concentrate (d), secondary concentrate (e), and insect oil (f) in the test example of the present invention. am.
Figure 2 is a photograph showing (a) insect oil and (b) garcinia as test substances used in animal testing.
Figure 3 is a graph showing the results of analyzing the effect of bug oil on the weekly body weight of an obese animal model caused by a high-fat diet.
Figure 4 is a graph showing the results of analyzing the effects of python oil on the weekly diet and water intake of an obese animal model caused by a high-fat diet.
Figure 5 is a graph showing the results of analyzing the effect of ragweed oil on the tissue weight of an obese animal model.
Figure 6 is a graph showing the results of analyzing the effect of ragweed oil on the concentrations of T-Chol, TG, LDL, and HDL in an obese animal model.
Figure 7 is a graph showing the results of analysis of the effect of bug oil on serum leptin concentration in an obese animal model.

이하 바람직한 실시예를 통하여 본 발명을 상세히 설명하기로 한다. 이에 앞서, 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여, 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서, 본 명세서에 기재된 실시예의 구성은 본 발명의 가장 바람직한 일실시예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다. 또한, 명세서 전체에서, 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한, 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있음을 의미한다.Hereinafter, the present invention will be described in detail through preferred embodiments. Prior to this, the terms or words used in this specification and claims should not be construed as limited to their usual or dictionary meanings, and the inventor should appropriately define the concept of terms in order to explain his or her invention in the best way. Based on the principle of definability, it must be interpreted with meaning and concept consistent with the technical idea of the present invention. Therefore, the configuration of the embodiments described in this specification is only one of the most preferred embodiments of the present invention and does not represent the entire technical idea of the present invention, so various equivalents and modifications can be substituted for them at the time of filing the present application. You must understand that there may be. Additionally, throughout the specification, when a part is said to “include” a certain element, this means that, unless specifically stated to the contrary, it does not exclude other elements but may further include other elements.

본 발명에서는 곤쟁이 오일의 동물시험에서 체중 감소, 간 지방 조직 및 부고환 지방 중량 감소, 혈중 콜레스테롤, LDL 및 HDL 함량 감소의 유의한 결과를 확인하였다. 따라서, 본 발명은 곤쟁이 오일을 포함하는 항비만용 식품 조성물을 개시한다.In the present invention, significant results of weight loss, reduction in liver adipose tissue and epididymal fat, and reduction in blood cholesterol, LDL, and HDL contents were confirmed in animal tests of snail oil. Accordingly, the present invention discloses a food composition for anti-obesity containing chamomile oil.

본 발명에서 상기 지표와 관련된 항비만 효능 증대를 위해 곤쟁이 오일은 (a)추출 단계, (b) 1차 여과 및 농축 단계 및 (c) 2차 여과 및 농축 단계를 거쳐 제조된다.In the present invention, in order to increase the anti-obesity efficacy related to the above indicators, python oil is prepared through (a) extraction step, (b) primary filtration and concentration step, and (c) secondary filtration and concentration step.

상기 (a) 단계에서 추출 용매로 주정을 사용 시 항비만 효능 증대에 가장 효과적인 것으로 확인되었으며, 건조된 곤쟁이에 90 내지 100 %(v/v)의 주정을 10 내지 20배수 투입하여 추출하는 것이 바람직하다. 또한 (b) 단계에서는 (a) 단계의 추출물을 1차 여과 후 1차 감압농축하되 40 내지 60℃에서 수행되는 것이 바람직하고, (c) 단계에서는 농축된 추출물을 2차 여과 후 2차 감압농축하되, 50 내지 100℃에서 점도가 700 내지 1,000 cPs 수준이 될 때까지 농축하여 오일을 제조함으로써 항비만 효능을 극대화시킬 수 있게 된다.It was confirmed that the use of alcohol as an extraction solvent in step (a) was most effective in increasing anti-obesity efficacy, and it is preferable to extract by adding 10 to 20 times 90 to 100% (v/v) of alcohol to dried insects. do. In addition, in step (b), the extract from step (a) is first filtered and then first concentrated under reduced pressure, preferably at 40 to 60°C, and in step (c), the concentrated extract is second filtered and then second concentrated under reduced pressure. However, the anti-obesity effect can be maximized by producing the oil by concentrating it at 50 to 100°C until the viscosity reaches the level of 700 to 1,000 cPs.

본 발명에 따른 조성물은 식품 조성물의 형태로 제공되며, 예컨대, 기능성 식품(functional food), 영양 보조제(nutritional supplement), 건강식품(health food), 식품 첨가제(food additives) 등의 형태를 포함할 수 있다. 상기 유형의 식품 조성물은 당 업계에 공지된 통상적인 방법에 따라 다양한 형태로 제조할 수 있다.The composition according to the present invention is provided in the form of a food composition and may include, for example, the form of functional food, nutritional supplement, health food, food additives, etc. there is. Food compositions of this type can be prepared in various forms according to conventional methods known in the art.

예를 들면, 건강 식품으로는 상기 조성물 자체를 차, 주스 또는 드링크의 형태로 제조하여 음용하도록 하거나, 과립화, 캡슐화 또는 분말화하여 섭취할 수 있다. 또한 기능성 식품으로는 음료(알콜성 음료 포함), 과실 및 그의 가공식품(예: 과일통조림, 병조림, 잼, 마말레이드 등), 어류, 육류 및 그 가공식품(예: 햄, 소시지 콘비프 등), 빵류 및 면류(예: 우동, 메밀국수, 라면, 스파게티, 마카로니 등), 과즙, 각종 드링크, 쿠키, 엿, 유제품(예: 버터, 치즈 등), 식용식물유지, 마아가린, 식물성 단백질, 레토르트 식품, 냉동식품, 각종 조미료(예: 된장, 간장, 소스 등) 등에 추출물을 첨가하여 제조할 수 있다. 또한 본 발명의 조성물을 식품 첨가제의 형태로 사용하기 위해서는 분말 또는 농축액 형태로 제조하여 사용할 수 있다.For example, as a health food, the composition itself can be prepared and consumed in the form of tea, juice, or drink, or can be consumed by granulating, encapsulating, or powdering. In addition, functional foods include beverages (including alcoholic beverages), fruits and their processed foods (e.g. canned fruit, bottled foods, jam, marmalade, etc.), fish, meat and their processed foods (e.g. ham, sausages, corned beef, etc.), and breads. and noodles (e.g. udon, buckwheat noodles, ramen, spaghetti, macaroni, etc.), fruit juice, various drinks, cookies, taffy, dairy products (e.g. butter, cheese, etc.), edible vegetable oil, margarine, vegetable protein, retort food, frozen. It can be manufactured by adding extracts to food, various seasonings (e.g. soybean paste, soy sauce, sauce, etc.). Additionally, in order to use the composition of the present invention in the form of a food additive, it can be prepared and used in the form of a powder or concentrate.

본 발명에 따른 식품 조성물 중 상기 추출물 또는 오일의 바람직한 함량은 식품 조성물 총 중량에 대하여 0.001 내지 50%일 수 있으며, 바람직하게는 0.1 내지 10% 범위로 함유될 수 있다.The preferred content of the extract or oil in the food composition according to the present invention may be 0.001 to 50%, preferably 0.1 to 10%, based on the total weight of the food composition.

이하, 구체적인 실시예를 들어 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail through specific examples.

곤쟁이 오일 제조Mandarin oil production

하기 표 1의 영양성분으로 구성된 냉동 곤쟁이 생물(원물)(개체 크기 약 1 cm) 30 kg을 상온에서 해동 및 24시간 열풍건조(50℃ 8시간, 70℃ 8시간 및 80℃ 8시간)하여 하기 표 2의 영양성분으로 구성된 곤쟁이 열풍건조 건물(수율 13%)을 준비하였다. 이후, 곤쟁이 건물에 95 %(v/v) 주정을 15 배수로 투입하고 1시간 동안 추출하였다. 이후, 곤쟁이 추출물을 여과 필터로 1차 여과한 후 50℃에서 1차 감압농축하고, 다시 여과 필터로 2차 여과한 후 50 내지 100℃에서 점도가 800 내지 900 cPs가 될 때까지 2차 감압농축하여 곤쟁이 오일을 회수하였다. 도 1에 상기 과정에서 곤쟁이 원물(a), 열풍건조물(b), 추출물(c), 1차 농축물(d), 2차 농축물(e) 및 곤쟁이 오일(f)을 나타내었고, 곤쟁이 오일의 성분 및 품질 분석 결과를 하기 표 3에 나타내었다.30 kg of frozen insect organisms (raw material) (individual size about 1 cm) consisting of the nutrients shown in Table 1 below were thawed at room temperature and dried with hot air for 24 hours (50°C for 8 hours, 70°C for 8 hours, and 80°C for 8 hours). We prepared hot-air dried dried insects (yield 13%) consisting of the nutrients shown in Table 2. Afterwards, 15 times 95% (v/v) alcohol was added to the dried bean sprouts and extracted for 1 hour. Afterwards, the insect extract was first filtered using a filtration filter, first concentrated under reduced pressure at 50°C, secondly filtered again with a filter, and then secondarily concentrated under reduced pressure at 50 to 100°C until the viscosity reached 800 to 900 cPs. In this way, the insect oil was recovered. Figure 1 shows the raw material (a), hot air dried material (b), extract (c), primary concentrate (d), secondary concentrate (e), and insect oil (f) in the above process. The ingredients and quality analysis results are shown in Table 3 below.

영양성분nutrient 함량(중량%)Content (% by weight) 수분moisture 8787 단백질protein 1111 지방province 1One 회분batch 33

영양성분nutrient 함량(중량%)Content (% by weight) 수분moisture 99 단백질protein 7171 지방province 55 회분batch 1515

구분division 단위unit value 품질 분석quality analysis 수분moisture 중량%weight% 55 산가(AV)Acid value (AV) mg KOH/gmg KOH/g 4040 과산화물가(POV)Peroxide value (POV) meq/kgmeq/kg 2.72.7 중금속heavy metal mg/kgmg/kg 납 0.1 이하무기비소 0.1 이하Lead 0.1 or less Inorganic arsenic 0.1 or less 인지질 함량Phospholipid content 인지질Phospholipids 중량%weight% 6565 오메가 3 함량Omega 3 content EPAEPA 중량%weight% 88 DHADHA 중량%weight% 55 지방산 조성Fatty acid composition methyl myristatemethyl myristate 중량%weight% 10.7310.73 Methyl palmitateMethyl palmitate 중량%weight% 22.6922.69 Methyl palmitoleateMethyl palmitoleate 중량%weight% 4.174.17 Methyl stearatMethyl stearat 중량%weight% 1.251.25 Cis-9-oleic acid methyl esterCis-9-oleic acid methyl ester 중량%weight% 10.8110.81 Methyl linoleateMethyl linoleate 중량%weight% 1.881.88 Methyl linolenateMethyl linolenate 중량%weight% 3.023.02 Cis-11,14-eicosadienoic acid methyl esterCis-11,14-eicosadienoic acid methyl ester 중량%weight% 7.987.98 EPAEPA 중량%weight% 15.1215.12 DHADHA 중량%weight% 8.538.53 I.SI.S. 중량%weight% 14.114.1

시험방법Test Methods

(1) 시험물질의 조제(1) Preparation of test substances

본 시험에 사용된 시험물질을 하기 표 4에 정리하였고, 물질 사진을 도 2에 나타내었다.The test substances used in this test are summarized in Table 4 below, and a photo of the substances is shown in Figure 2.

시험물질test substance 시험 코드명test code name 외관 / 성상Appearance / Appearance 입수량Quantity 비고note 곤쟁이 오일snail oil NO (Neomysis awatschensis oil)NO (Neomysis awatschensis oil) 주황색 액체orange liquid 70 g70g 공시료
(도 2(a))
public sample
(Figure 2(a))
가르시니아garcinia GarciniaGarcinia 흰색/분말white/powder 2 g2g 양성시료
(도 2(b))
positive sample
(Figure 2(b))

시험물질은 실험에 사용하기 전 100% 발효 주정으로 먼저 곤쟁이 오일을 용하한다음 corn oil을 넣어 교반기를 이용하였으며, 최종 volume은 D.W를 이용하여 시료를 제작하였다. 각 시료의 농도별 희석은 D.W로 하였으며 제조된 시료는 냉장 보관하였다.Before using the test substance in the experiment, 100% fermented alcohol was first dissolved in 100% fermented alcohol, then corn oil was added and a stirrer was used. The final volume was prepared using D.W. Each sample was diluted by concentration using D.W, and the prepared sample was stored in a refrigerator.

(2) 실험동물 및 사육환경(2) Experimental animals and breeding environment

사육기간 중 온도는 23±1℃, 습도 50±5%, 소음 60 phone 이하, 조명시간 07:00-19:00(1일 12시간), 조도 150-300 lux, 환기는 시간당 10-12회의 환경을 유지하였다. 동물 입수 시 모든 동물의 일반 건강상태에 대한 수의학적 검역을 실시하며, 시험을 실시하는데 적합하도록 설치류용 일반사료(Samtoko, Gyeonggi, Korea)와 필터 및 자외선 살균기로 여과 살균된 정제수를 자유롭게 섭취하도록 하였다. 본 실험은 주식회사 인비보의 동물실험윤리규정을 준수하여 수행하였다(승인번호 IV-RA-04-2006-26).During the breeding period, the temperature is 23±1℃, humidity 50±5%, noise less than 60 phones, lighting hours 07:00-19:00 (12 hours a day), illuminance 150-300 lux, ventilation 10-12 times per hour. The environment was maintained. Upon receipt of animals, veterinary quarantine was conducted to check the general health of all animals, and they were allowed to freely consume general rodent feed (Samtoko, Gyeonggi, Korea) and purified water that had been filtered and sterilized with a filter and ultraviolet sterilizer to be suitable for conducting tests. . This experiment was conducted in compliance with the Animal Experiment Ethics Regulations of Invivo Co., Ltd. (Approval No. IV-RA-04-2006-26).

(3) 실험군 구성(3) Composition of experimental group

순화기간이 끝난 후 고지방식이와 곤쟁이 오일을 6주간 투여하며 비만을 유도 및 비만 억제를 확인하였다. 실험군은 정상군(Normal group), 대조군(비만유도군, Control group), 농도별 시험군(고지방식이와 곤쟁이 오일 시험물질, 저농도(NA 10 mg/kg), 고농도(NA 30 mg/kg)로 투여한 실험군), 양성대조군(고지방식이와 가르시니아 시험물질 200 mg/kg)으로 나누어 군당 10마리씩 설정하였다. 실험식이의 경우 정상군은 일반식이(샘타코, 한국)를 급여하고, 비만유도모델은 Rodent Diet with 60%Kcal Fat(새론바이오, 한국)를 급여하였다. After the acclimatization period was over, high-fat diet and beetle oil were administered for 6 weeks, and obesity was induced and obesity suppressed. The experimental group was the normal group, the control group (obesity-induced group), and the test group by concentration (high-fat diet and insect oil test substance, low concentration (NA 10 mg/kg), high concentration (NA 30 mg/kg). The animals were divided into a positive control group (high-fat diet and 200 mg/kg of Garcinia test substance) and a positive control group (10 animals per group). In the case of the experimental diet, the normal group was fed a regular diet (Sam Taco, Korea), and the obesity-induced model was fed a Rodent Diet with 60%Kcal Fat (Saeron Bio, Korea).

(4) 주간 바이오마커 분석 및 부검(4) Weekly biomarker analysis and autopsy

주간 체중변화는 주 1회 일정시간에 모든 실험군의 개체별 체중을 측정하고, 식이 섭취량은 급여 후 익일 잔량을 측정하여 주 1회 측정하였다. 부검은 호흡 마취 후 채혈하여 혈액 분석에 사용하고, 간(Liver)과 부고환지방(Epididymal fat)을 적출하여 무게를 측정하였다.Weekly weight change was measured by measuring the weight of each individual in all experimental groups at a certain time once a week, and dietary intake was measured once a week by measuring the remaining amount the day after feeding. For the autopsy, blood was collected after respiratory anesthesia and used for blood analysis, and the liver and epididymal fat were extracted and weighed.

(5) 혈액 분석(5) Blood analysis

동물 부검 시 복대정맥에서 채혈하고 30분 동안 응고 과정을 거친 후 원심분리기로 10분 동안 3,000 rpm으로 원심 분리하여 혈청을 회수하였다. 회수한 혈청을 TC(Total cholesterol), TG(Triglyceride), HDL-C(high density lipoprotein cholesterol) 및 LDL-C(Low density lipoprotein cholesterol) 분석에 사용, 녹십자 의료재단(GC Labs, 한국)에 분석을 의뢰하였고, 혈중 leptin 함량은 ELISA kit(ab199082; Abcam)를 이용하여 분석하였다.At the time of animal autopsy, blood was collected from the abdominal vena cava, coagulated for 30 minutes, and then centrifuged at 3,000 rpm for 10 minutes to recover serum. The recovered serum was used for analysis of TC (Total cholesterol), TG (Triglyceride), HDL-C (high density lipoprotein cholesterol), and LDL-C (Low density lipoprotein cholesterol), and was analyzed by the Green Cross Medical Foundation (GC Labs, Korea). The request was made, and the leptin content in the blood was analyzed using an ELISA kit (ab199082; Abcam).

(6) 통계 분석(6) Statistical analysis

각 군 간의 통계적 유의성 검정에 따른 통계분석은 ANOVA(one-way analysis of variance test) Duncan 사후검정 비교를 실시하여 p<0.05일 때 유의한 것으로 판정하였다(SPSS V12., SPSS Inc, Chicago, IL, USA).Statistical analysis according to the statistical significance test between each group was performed using ANOVA (one-way analysis of variance test) and Duncan's post hoc test comparison, and p < 0.05 was judged to be significant (SPSS V12., SPSS Inc, Chicago, IL, USA).

시험결과Test result

(1) 주간 체중 및 식이음수 섭취량 변화(1) Changes in weekly weight and dietary water intake

도 3은 곤쟁이 오일이 고지방식이에 의한 비만 동물모델의 주간 체중에 미치는 영향을 분석한 결과를 나타낸 그래프이다. Figure 3 is a graph showing the results of analyzing the effect of bug oil on the weekly body weight of an obese animal model caused by a high-fat diet.

도 3을 참조하면, 곤쟁이 오일이 고지방식이로 유도된 비만 동물모델에서의 체중 증가에 대한 효과를 조사하기 위해 고지방 식이 공급과 함께 농도별 곤쟁이 오일을 경구투여 하여 6주간 비만을 유도하며 체중을 조사한 결과, 실험 4주차에서부터 각 실험군별 체중의 차이가 유의적으로 차이를 보였으며, 정상군(Normal)이 25.62±0.28 g, 대조군(Control)이 28.29±0.74 g으로 대조군이 정상군에 비해 유의적으로 높게 나타났으며, 곤쟁이 오일 저농도(NO10)는 26.65±1.18 g, 곤쟁이 오일 고농도(NO30)는 27.70±0.96 g, 실험대조군(Garcinia)은 28.50±0.76 g로 대조군과 비교하여 저농도, 고농도 투여군 순으로 체중증가율이 감소하였다. 실험 종료 시점인 6주차 기준으로 정상군(Normal)은 26.95±0.28 g, 대조군(Control)은 34.01±0.74 g으로 정상군과 비교시 체중증가율이 유의적인 차이를 보였고, 곤쟁이 오일 저농도(NO10)는 30.06±1.18 g, 곤쟁이 오일 고농도(NO30)는 32.15±0.96 g, 실험대조군(Garcinia)은 32.71±0.76 g로 곤쟁이 오일 저농도, 고농도 투여군 순으로 체중이 낮은 것으로 확인되었다.Referring to FIG. 3, in order to investigate the effect of snail oil on weight gain in an obese animal model induced by a high-fat diet, snail oil of various concentrations was orally administered along with a high-fat diet to induce obesity for 6 weeks and increase body weight. As a result of the investigation, there was a significant difference in body weight between each experimental group from the 4th week of the experiment, with the Normal group being 25.62±0.28 g and the Control group being 28.29±0.74 g, which was significant compared to the normal group. It was found to be relatively high, with the low concentration of impatiens oil (NO10) being 26.65±1.18 g, the high concentration of impregnation oil (NO30) being 27.70±0.96 g, and the experimental control group (Garcinia) being 28.50±0.76 g. Compared to the control group, the low and high concentration administration groups were In that order, the weight gain rate decreased. At the end of the experiment, at week 6, the normal group (Normal) was 26.95 ± 0.28 g and the control group (Control) was 34.01 ± 0.74 g, showing a significant difference in weight gain rate compared to the normal group, and the low concentration of bee oil (NO10) was Body weight was confirmed to be lower in that order: 30.06 ± 1.18 g, high concentration of benign oil (NO30) was 32.15 ± 0.96 g, and 32.71 ± 0.76 g for the experimental control group (Garcinia).

(2) 주간 식이 및 음수 섭취량(2) Weekly dietary and water intake

도 4는 곤쟁이 오일이 고지방식이에 의한 비만 동물모델의 주간 식이 및 음수 섭취량에 미치는 영향을 분석한 결과를 나타낸 그래프이다. 도 4에서 A는 식이 섭취량, B는 음수 섭취량을 나타낸다.Figure 4 is a graph showing the results of analyzing the effects of python oil on the weekly diet and water intake of an obese animal model caused by a high-fat diet. In Figure 4, A represents dietary intake and B represents drinking water intake.

도 4를 참조하면, 비만 유도동물에서 곤쟁이 오일이 주간섭취량과 음수섭취량에 미치는 영향을 확인하기 위해 각 군간 식이 음수 섭취량을 측정한 결과, 각 실험군의 식이섭취량은 6주차를 기준으로 정상군(Normal)이 3.35±0.12 g로 나타났으며, 대조군(Control)은 1.86±0.16 g, 곤쟁이 오일 저농도(10 mg/kg, NO10)는 1.97±0.17 g, 곤쟁이 오일 고농도(30 mg/kg, NO30)는 1.87±0.19 g, 실험대조군(Garcinia)은 1.97±0.15 g으로 나타났다. 또한 6주차 기준 음수섭취량은 정상군(Normal)은 4.11±0.10 g, 대조군(Control)은 2.15±0.17 g, 곤쟁이 오일 저농도(10 mg/kg, NO10)는 2.59±0.29 g, 곤쟁이 오일 고농도(30 mg/kg, NO30)는 2.40±0.35 g, 실험대조군(Garcinia)은 2.46±0.44 g으로 조사되었다. 시험기간 중 식이섭취량과 음수섭취량은 고지방식이를 섭취하는 대조군과 실험군에 비해 일반 식이를 섭취하는 정상군이 비교적 높은 양상을 보였으나, 실험군 간에는 차이를 보이지 않았다.Referring to FIG. 4, as a result of measuring dietary water intake between each group to confirm the effect of snail oil on the weekly intake and water intake in obesity-induced animals, the dietary intake of each experimental group was normal based on the 6th week. ) was found to be 3.35 ± 0.12 g, the control group was 1.86 ± 0.16 g, the low concentration of gopher oil (10 mg/kg, NO10) was 1.97 ± 0.17 g, and the high concentration of gonorrhea oil (30 mg/kg, NO30) was 1.97 ± 0.17 g. It was 1.87±0.19 g, and the experimental control group (Garcinia) was 1.97±0.15 g. In addition, the drinking water intake as of week 6 was 4.11 ± 0.10 g for the Normal group, 2.15 ± 0.17 g for the Control group, 2.59 ± 0.29 g for low-concentration benix oil (10 mg/kg, NO10), and 2.59 ± 0.29 g for high-concentration benix oil (30 mg/kg, NO10). mg/kg, NO30) was found to be 2.40±0.35 g, and the experimental control group (Garcinia) was found to be 2.46±0.44 g. During the test period, dietary intake and water intake were relatively higher in the normal group consuming a normal diet compared to the control group and experimental group consuming a high-fat diet, but there was no difference between the experimental groups.

(3) 조직 중량(3) Tissue weight

도 5는 곤쟁이 오일이 비만 동물모델의 조직 중량에 미치는 영향을 분석한 결과를 나타낸 그래프이다. 도 5에서 A는 간 중량, B는 부고환 지방 중량을 나타낸다.Figure 5 is a graph showing the results of analyzing the effect of bug oil on the tissue weight of an obese animal model. In Figure 5, A represents the liver weight and B represents the epididymal fat weight.

도 5를 참조하면, 비만 동물모델에서 곤쟁이 오일을 농도별로 투여했을 때 간 지방 조직 중량과 부고환 지방 중량에 미치는 영향을 분석한 결과, 비만 동물모델의 조직 중량에 미치는 영향을 확인한 시험 중 먼저 간 조직의 중량을 측정한 시험에서 정상군(Normal)은 1.11±0.02 g, 대조군(Control)은 1.15±0.03 g으로 대조군이 정상군에 비해 간 조직의 중량이 증가하는 경향을 보이는 것으로 확인되었다. 반면, 곤쟁이 오일 저농도(10 mg/kg, NO10) 실험군은 1.00±0.02 g, 곤쟁이 오일 고농도(30 mg/kg, NO30) 실험군은 1.03±0.03 g, 실험대조군(Garcinia)은 1.06±0.02 g으로 나타나, 모든 실험군에서 대조군과 유의적인 차이를 보였다. 특히, 곤쟁이 오일 저농도, 고농도 수준으로 감소되는 것으로 나타났다.Referring to FIG. 5, as a result of analyzing the effect on liver adipose tissue weight and epididymal fat weight when administered at different concentrations in an obese animal model, liver tissue was first tested to determine the effect on the tissue weight of an obese animal model. In a test measuring the weight, the normal group (Normal) was 1.11 ± 0.02 g and the control group (Control) was 1.15 ± 0.03 g, and it was confirmed that the control group showed a tendency to increase the weight of liver tissue compared to the normal group. On the other hand, the experimental group with low concentration of insect oil (10 mg/kg, NO10) showed 1.00±0.02 g, the experimental group with high concentration of insect oil (30 mg/kg, NO30) showed 1.03±0.03 g, and the experimental control group (Garcinia) showed 1.06±0.02 g. , All experimental groups showed significant differences from the control group. In particular, it was found to be reduced at low and high concentrations of gopher oil.

부고환 지방 조직의 경우 정상군(Normal)이 0.32±0.02 g으로 대조군(Control)의 1.79±0.13 g과 비교하여 대조군이 유의하게 증가되었다. 실험군별로는 곤쟁이 오일 저농도(10 mg/kg, NO10) 실험군은 1.36±0.13 g, 곤쟁이 오일 고농도(30 mg/kg, NO30) 실험군은 1.52±0.07 g, 실험대조군(Garcinia)은 1.76±0.13 g으로, 곤쟁이 오일 저농도, 고농도 순으로 부고환 지방 조직의 무게가 감소된 것으로 확인되었다.In the case of epididymal fat tissue, the normal group (Normal) was 0.32 ± 0.02 g, which was significantly increased compared to the control group (1.79 ± 0.13 g). By experimental group, the experimental group with low concentration of insect oil (10 mg/kg, NO10) was 1.36±0.13 g, the experimental group with high concentration of insect oil (30 mg/kg, NO30) was 1.52±0.07 g, and the experimental control group (Garcinia) was 1.76±0.13 g. It was confirmed that the weight of epididymal adipose tissue was reduced in the order of low and high concentrations of insect oil.

(4) 일반 혈액학적 분석(4) General hematological analysis

도 6은 곤쟁이 오일이 비만 동물모델의 T-Chol, TG, LDL, HDL 농도에 미치는 영향을 분석한 결과를 나타낸 그래프이다.Figure 6 is a graph showing the results of analyzing the effect of ragweed oil on the concentrations of T-Chol, TG, LDL, and HDL in an obese animal model.

도 6을 참조하면, 비만 동물모델에서 곤쟁이 오일이 혈중 T-Chol(Total cholesterol), TG(Triglyceride), LDL(Low-density lipoprotein) 및 HDL(High-density lipoprotein) 농도에 미치는 영향을 확인하기 위하여 측정한 결과, 혈중 총 콜레스테롤의 함량은 정상군(Normal)의 경우 114.63±2.28 mg/dL로 대조군의 202.88±9.99 mg/dL보다 유의적인 차이를 보였으며, 곤쟁이 오일 고농도(30 mg/kg, NO30) 실험군이 207.50±7.30 mg/dL, 실험대조군(Garcinia)이 208.63±12.73 mg/dL로 대조군과 비슷한 경향을 보였으나, 곤쟁이 오일 저농도(10 mg/kg, NO10) 실험군은 177.88±8.55 mg/dL로 대조군에 비해 감소하는 경향을 보였다.Referring to Figure 6, in order to confirm the effect of dandelion oil on blood T-Chol (Total cholesterol), TG (Triglyceride), LDL (Low-density lipoprotein), and HDL (High-density lipoprotein) concentrations in an obese animal model. As a result of the measurement, the total cholesterol content in the blood was 114.63 ± 2.28 mg/dL in the normal group, which was significantly different from 202.88 ± 9.99 mg/dL in the control group. ) The experimental group showed a similar tendency to the control group at 207.50±7.30 mg/dL and the experimental control group (Garcinia) at 208.63±12.73 mg/dL, but the low concentration of benign oil (10 mg/kg, NO10) experimental group showed 177.88±8.55 mg/dL. showed a tendency to decrease compared to the control group.

혈중 LDL cholesterol을 측정한 결과, 정상군(Normal)이 9.89±0.35 mg/dL, 대조군(Control)이 36.29±1.83 mg/dL로 유의적인 차이를 보였다. 실험군별로는 곤쟁이 오일 저농도(10 mg/kg, NO10) 실험군이 26.80±2.25 mg/dL, 곤쟁이 오일 고농도(30 mg/kg, NO30) 실험군이 32.00±1.76 mg/dL, 실험대조군(Garcinia) 실험군이 34.21±2.06 mg/dL로 나타나, 대조군과 비교하여 곤쟁이 오일을 투여한 실험군에서 저농도 투여군에서 혈중 LDL 함량이 유의적으로 낮게 감소하는 것으로 확인되었다. As a result of measuring LDL cholesterol in the blood, there was a significant difference between the Normal group (9.89 ± 0.35 mg/dL) and the Control group (36.29 ± 1.83 mg/dL). By experimental group, the low-concentration insect oil (10 mg/kg, NO10) experimental group was 26.80±2.25 mg/dL, the high-concentration insect oil (30 mg/kg, NO30) experimental group was 32.00±1.76 mg/dL, and the control group (Garcinia) experimental group was 34.21. It was found to be ±2.06 mg/dL, and compared to the control group, it was confirmed that the blood LDL content was significantly reduced in the low concentration group in the experimental group administered dandelion oil.

혈중 TG(Triglyceride)를 측정한 결과, 정상군의 185.50±24.23 mg/dL에 비해 대조군은 292.13±9.39 mg/dL로 유의적인 차이를 보였으며, 곤쟁이 오일 저농도(10 mg/kg, NO10) 실험군이 273.88±3.89 mg/dL, 곤쟁이 오일 고농도(30 mg/kg, NO30) 실험군이 281.63±8.70 mg/dL, 실험대조군(Garcinia) 실험군이 285.88±4.52 mg/dL로, 대조군과 비교하여 실험군간 유의적인 차이는 나타나지 않았다.As a result of measuring TG (Triglyceride) in the blood, the control group showed a significant difference of 292.13 ± 9.39 mg/dL compared to the normal group's 185.50 ± 24.23 mg/dL, and the low-concentration benign oil (10 mg/kg, NO10) experimental group showed a significant difference. 273.88±3.89 mg/dL, 281.63±8.70 mg/dL in the high-concentration bean oil (30 mg/kg, NO30) experimental group, and 285.88±4.52 mg/dL in the experimental control (Garcinia) experimental group. There was a significant difference between the experimental groups compared to the control group. No difference appeared.

혈중 HDL cholesterol을 측정한 결과, 정상군(Normal)이 103.93±2.46 mg/dL, 대조군(Control)이 159.45±6.34 mg/dL로 나타났고, 실험군별로는 곤쟁이 오일 저농도(10 mg/kg, NO10) 실험군이 146.10±5.42 mg/dL, 곤쟁이 오일 고농도(30 mg/kg, NO30) 실험군이 172.81±5.60 mg/dL, 실험대조군(Garcinia) 실험군이 170.45±10.24 mg/dL로 나타나, 대조군과 비교하여 곤쟁이 오일을 저농도로 투여한 실험군이 낮은 경향을 보였다.As a result of measuring HDL cholesterol in the blood, the normal group (Normal) was found to be 103.93 ± 2.46 mg/dL and the control group (Control) was 159.45 ± 6.34 mg/dL. By experimental group, the low-concentration benign oil (10 mg/kg, NO10) experimental group This was 146.10±5.42 mg/dL, the high-concentration garcinia oil (30 mg/kg, NO30) experimental group was 172.81±5.60 mg/dL, and the experimental control group (Garcinia) was 170.45±10.24 mg/dL, compared to the control group. The experimental group administered at a low concentration tended to have lower levels.

(5) 사이토카인 분석(5) Cytokine analysis

도 7은 곤쟁이 오일이 비만 동물모델의 혈청 Leptin 농도에 미치는 영향을 분석한 결과를 나타낸 그래프이다.Figure 7 is a graph showing the results of analysis of the effect of bug oil on serum leptin concentration in an obese animal model.

지방조직에서 생산되는 Obese(Ob) 유전자의 사이토카인으로 식욕을 억제하고 포만감을 느끼게 하는 호로몬으로 식욕과 에너지 대사를 조절한다. 비만인 경우 leptin의 분비량이 증가하는 것으로 알려져 있어 체지방량을 나타내는 지표로 비만연구에 많이 사용되어진다. 도 7을 참조하면, 비만 동물모델에서 곤쟁이 오일의 항비만 효과를 확인하기 위하여 혈청 Leptin의 양을 측정하여 분석한 결과, 정상군(Normal)의 경우 535.3±108.8 pg/ml로 대조군의 5088.7±476.8 pg/ml보다 유의하게 낮았다. 반면, 곤쟁이 오일 저농도(10 mg/kg, NO10) 실험군은 3629.9±624.8 pg/ml, 곤쟁이 오일 고농도(30 mg/kg, NO30) 실험군은 4043.7±525.4 pg/ml, 실험대조군(Garcinia)은 5176.8±406.6 pg/ml로 조사되어, 대조군(Control)군에 비해 곤쟁이 오일을 투여한 실험군에서 혈중 leptin의 농도가 감소하는 경향을 보이거나 유의하게 감소된 것으로 확인되었다.It is a cytokine of the Obese (Ob) gene produced in adipose tissue and is a hormone that suppresses appetite and causes a feeling of fullness. It regulates appetite and energy metabolism. It is known that leptin secretion increases in the case of obesity, so it is often used in obesity research as an indicator of body fat mass. Referring to Figure 7, the amount of serum leptin was measured and analyzed to confirm the anti-obesity effect of gnatia oil in an obese animal model. As a result, the amount was 535.3 ± 108.8 pg/ml in the normal group, compared to 5088.7 ± 476.8 in the control group. It was significantly lower than pg/ml. On the other hand, the experimental group with low concentration of insect oil (10 mg/kg, NO10) was 3629.9±624.8 pg/ml, the experimental group with high concentration of insect oil (30 mg/kg, NO30) was 4043.7±525.4 pg/ml, and the experimental control group (Garcinia) was 5176.8±. It was found to be 406.6 pg/ml, and it was confirmed that the concentration of leptin in the blood tended to decrease or was significantly decreased in the experimental group administered dandelion oil compared to the control group.

이와 같이, 곤쟁이 오일은 체중 감소, 간 지방 조직 및 부고환 지방 중량 감소, 혈중 콜레스테롤, LDL 및 HDL 함량 감소의 유의한 결과로부터 항비만 효능이 우수한 것으로 확인되었다.In this way, it has been confirmed that gnatia oil has excellent anti-obesity efficacy, with significant results in weight loss, reduction in liver adipose tissue and epididymal fat weight, and reduction in blood cholesterol, LDL, and HDL contents.

이하에서는 본 발명에 따른 곤쟁이 오일을 포함하는 항비만용 식품 조성물의 적용 제조예를 설명하나, 이에 한정되는 것은 아니다.Hereinafter, a manufacturing example of the application of the anti-obesity food composition containing the insect oil according to the present invention will be described, but it is not limited thereto.

제조예 1: 산제 제조Preparation Example 1: Powder preparation

하기 표 5에서는 상술한 본 발명에 따른 곤쟁이 오일을 포함하는 항비만용 식품 조성물의 산제 조성을 예시하고 있다. 산제는 하기 성분들을 혼합하고 기밀포에 충진하여 제조될 수 있다.Table 5 below illustrates the powder composition of the anti-obesity food composition containing the insect oil according to the present invention described above. Powder can be prepared by mixing the following ingredients and filling them in an airtight bubble.

성분ingredient 함량content 곤쟁이 오일snail oil 200 ㎎200 mg 유당lactose 100 ㎎100 mg 탈크Talc 10 ㎎10 mg

제조예 2: 정제 제조Preparation Example 2: Tablet Preparation

하기 표 6에서는 상술한 본 발명에 따른 곤쟁이 오일을 포함하는 항비만용 식품 조성물의 정제 조성을 예시하고 있다. 정제는 하기 성분들을 혼합한 후 통상의 정제 제조방법에 따라 타정하여 제조될 수 있다.Table 6 below illustrates the tablet composition of the anti-obesity food composition containing the insect oil according to the present invention described above. Tablets can be manufactured by mixing the following ingredients and compressing them according to a conventional tablet manufacturing method.

성분ingredient 함량content 곤쟁이 오일snail oil 200 ㎎200 mg 옥수수전분corn starch 100 ㎎100 mg 유당lactose 100 ㎎100 mg 스테아린산 마그네슘Magnesium Stearate 2 ㎎2mg

제조예 3: 캅셀제 제조Preparation Example 3: Capsule preparation

하기 표 7에서는 상술한 본 발명에 따른 곤쟁이 오일을 포함하는 항비만용 식품 조성물의 캅셀제 조성을 예시하고 있다. 캅셀제는 통상의 캅셀제 제조방법에 따라 하기 성분들을 혼합하고 젤라틴 캡슐에 충전하여 제조될 수 있다.Table 7 below illustrates the capsule composition of the anti-obesity food composition containing the insect oil according to the present invention described above. Capsules can be manufactured by mixing the following ingredients and filling them into gelatin capsules according to a typical capsule manufacturing method.

성분ingredient 함량content 곤쟁이 오일snail oil 200 ㎎200 mg 결정성 셀룰로오스crystalline cellulose 3 ㎎3mg 락토오스lactose 14.8 ㎎14.8 mg 스테아린산 마그네슘Magnesium stearate 0.2 ㎎0.2 mg

제조예 4: 액제 제조Preparation Example 4: Liquid preparation

하기 표 8에서는 상술한 본 발명에 따른 곤쟁이 오일을 포함하는 항비만용 식품 조성물의 액제 조성을 예시하고 있다. 액제는 통상의 액제 제조방법에 따라 정제수에 각각의 하기 성분들을 가하여 용해시키고 레몬향을 적량 가한 후 하기 성분들을 혼합한 다음 정제수를 가하여 전체 100 ㎖로 조절한 후 갈색병에 충진 및 멸균시켜 제조될 수 있다.Table 8 below illustrates the liquid composition of the anti-obesity food composition containing the insect oil according to the present invention described above. The liquid can be prepared by adding and dissolving each of the following ingredients in purified water according to a typical liquid preparation method, adding an appropriate amount of lemon flavor, mixing the following ingredients, adding purified water to adjust the total to 100 ml, and then filling and sterilizing it in a brown bottle. You can.

성분ingredient 함량content 곤쟁이 오일snail oil 200 ㎎200 mg 이성화당Iseonghwadang 10 g10g 만니톨mannitol 5 g5g 정제수Purified water 적량Appropriate amount

제조예 5: 건강 식품 제조Preparation Example 5: Preparation of health food

하기 표 9에서는 상술한 본 발명에 따른 곤쟁이 오일을 포함하는 항비만용 식품 조성물의 기능성 건강 식품 조성을 나타내고 있다. 하기 조성에서 비타민 및 미네랄 혼합물의 조성비는 비교적 건강 식품에 적합한 성분을 바람직한 제제예로 혼합 조성한 것을 나타내고 있으나, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강 식품 제조방법에 따라 각 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강 식품 조성물 제조에 사용할 수 있다.Table 9 below shows the functional health food composition of the anti-obesity food composition containing the insect oil according to the present invention described above. In the composition below, the composition ratio of the vitamin and mineral mixture represents a mixture of ingredients relatively suitable for health food as a preferred preparation example, but the mixing ratio may be modified arbitrarily, and each component is mixed according to a typical health food manufacturing method. Then, granules can be prepared and used to prepare health food compositions according to conventional methods.

성분ingredient 함량content 성분ingredient 함량content 곤쟁이 오일snail oil 1000 ㎎1000 mg 엽산folic acid 50 ㎍50 μg 비타민 혼합물vitamin mixture 적량Appropriate amount 판토텐산 칼슘Calcium Pantothenate 0.5 ㎎0.5 mg 비타민 A 아세테이트Vitamin A Acetate 70 ㎍70 ㎍ 무기질 혼합물mineral mixture 적량Appropriate amount 비타민 EVitamin E 1.0 ㎎1.0 mg 황산제1철Ferrous sulfate 1.75 ㎎1.75 mg 비타민 B1Vitamin B1 0.13 ㎎0.13 mg 산화아연zinc oxide 0.82 ㎎0.82 mg 비타민 B2Vitamin B2 0.15 ㎎0.15 mg 탄산마그네슘Magnesium Carbonate 25.3 ㎎25.3 mg 비타민 B6Vitamin B6 0.5 ㎎0.5 mg 제1인산칼륨Potassium Phosphate Monobasic 15 ㎎15 mg 비타민 B12Vitamin B12 0.2 ㎍0.2 μg 제2인산칼륨potassium phosphate dibasic 55 ㎎55 mg 비타민 CVitamin C 10 ㎎10 mg 구연산칼륨potassium citrate 90 ㎎90 mg 비오틴biotin 10 ㎍10 μg 탄산칼슘calcium carbonate 100 ㎎100 mg 니코틴산아미드Nicotinic acid amide 1.7 ㎎1.7 mg 염화마그네슘Magnesium chloride 24.8 ㎎24.8 mg

제조예 6: 건강 음료 제조Preparation Example 6: Preparation of health drink

하기 표 10에서는 상술한 본 발명에 따른 곤쟁이 오일을 포함하는 항비만용 식품 조성물의 기능성 건강 음료 조성을 나타내고 있다. 건강 음료 제조는 통상의 건강 음료 제조방법에 따라 예컨대, 하기 성분을 혼합한 다음, 약 1시간 동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 ℓ 용기에 취득하여 밀봉 멸균한 후 냉장 보관하여 사용할 수 있다. 하기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였으나, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.Table 10 below shows the functional health drink composition of the anti-obesity food composition containing the insect oil according to the present invention described above. The production of a health drink follows a typical health drink production method, for example, mixing the following ingredients, stirring and heating at 85°C for about 1 hour, filtering the resulting solution, placing it in a sterilized 2 liter container, sealing and sterilizing it. It can be stored refrigerated and used. The following composition ratio is a mixture of ingredients that are relatively suitable for beverages of choice as a preferred example, but the mixing ratio may be arbitrarily modified depending on regional and ethnic preferences such as demand class, demand country, and usage purpose.

성분ingredient 함량content 곤쟁이 오일snail oil 1000 ㎎1000 mg 구연산citric acid 1000 ㎎1000 mg 올리고당oligosaccharide 100 g100g 매실농축액plum concentrate 2 g2g 타우린taurine 1 g1g 정제수 혼합Purified Water Mix 전체 900 ㎖Total 900 ml

이상에서 설명한 본 발명의 바람직한 실시예들은 기술적 과제를 해결하기 위해 개시된 것으로, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 본 발명의 사상 및 범위 안에서 다양한 수정, 변경, 부가 등이 가능할 것이며, 이러한 수정 변경 등은 이하의 특허청구범위에 속하는 것으로 보아야 할 것이다.The preferred embodiments of the present invention described above were disclosed to solve technical problems, and those skilled in the art will be able to make various modifications, changes, additions, etc. within the spirit and scope of the present invention. , such modifications and changes should be regarded as falling within the scope of the patent claims below.

Claims (3)

(a) 건조된 곤쟁이에 90 내지 100 %(v/v)의 주정을 10 내지 20배수 투입하여 추출하는 단계;
(b) 상기 (a) 단계의 추출물을 1차 여과 후 40 내지 60℃에서 1차 감압농축하는 단계; 및
(c) 상기 (b) 단계의 농축물을 2차 여과 후 50 내지 100℃에서 2차 감압농축하여 점도 700 내지 1,000 cPs의 오일을 제조하는 단계;
를 포함하는 항비만용 곤쟁이 오일 제조방법으로서,
상기 곤쟁이 오일은 비만 유도 동물모델에서 체중 감소, 간 지방 조직 및 부고환 지방 중량 감소 및 혈중 렙틴(Leptin) 농도 감소를 통해 확인된 항비만 효능을 나타내는 유효성분이고,
상기 곤쟁이 오일의 인지질 함량은 60 내지 70 중량%인 것을 특징으로 하는 항비만용 곤쟁이 오일 제조방법.
(a) extracting 90 to 100% (v/v) alcohol by adding 10 to 20 times the amount of alcohol to the dried insect;
(b) first filtering the extract of step (a) and then first concentrating it under reduced pressure at 40 to 60°C; and
(c) secondary filtration of the concentrate from step (b) and secondary concentration under reduced pressure at 50 to 100°C to produce an oil with a viscosity of 700 to 1,000 cPs;
As a method for producing anti-obesity insect oil comprising,
The bug oil is an active ingredient that exhibits anti-obesity efficacy confirmed through weight loss, reduction in liver adipose tissue and epididymal fat weight, and reduction in blood leptin concentration in an obesity-inducing animal model,
A method for producing anti-obesity chamomile oil, characterized in that the phospholipid content of the chamomile oil is 60 to 70% by weight.
삭제delete 삭제delete
KR1020210057667A 2021-05-04 2021-05-04 A food composition comprising Neomysis awatschensis oil for anti-obesity KR102631920B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210057667A KR102631920B1 (en) 2021-05-04 2021-05-04 A food composition comprising Neomysis awatschensis oil for anti-obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210057667A KR102631920B1 (en) 2021-05-04 2021-05-04 A food composition comprising Neomysis awatschensis oil for anti-obesity

Publications (2)

Publication Number Publication Date
KR20220150551A KR20220150551A (en) 2022-11-11
KR102631920B1 true KR102631920B1 (en) 2024-01-31

Family

ID=84042628

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210057667A KR102631920B1 (en) 2021-05-04 2021-05-04 A food composition comprising Neomysis awatschensis oil for anti-obesity

Country Status (1)

Country Link
KR (1) KR102631920B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102222043B1 (en) * 2020-08-07 2021-03-04 주식회사 동원에프앤비 Method of krill oil preparation and composition of krill oil

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021045554A1 (en) * 2019-09-05 2021-03-11 장영진 Pharmaceutical composition comprising processed fish product and/or processed soybean product as active ingredient

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102222043B1 (en) * 2020-08-07 2021-03-04 주식회사 동원에프앤비 Method of krill oil preparation and composition of krill oil

Also Published As

Publication number Publication date
KR20220150551A (en) 2022-11-11

Similar Documents

Publication Publication Date Title
World Health Organization et al. Keep fit for life: meeting the nutritional needs of older persons
CN102178086B (en) Feed additive for improving quality and flavor of pork, feed, and preparation method thereof
CN101632655A (en) Resveratrol and bioflavonoid nutritional composition for delaying senility
JP2008174539A (en) Healthy and functional food for obesity patient using purple-colored potato
KR101791206B1 (en) The onion juice and method of it
KR20190003304A (en) Composition for preventing, improving or treating fatty liver disease comprising Gryllus bimaculatus extract as effective component
US8663725B2 (en) Method for deriving a high-protein powder/ omega 3 oil and double distilled water from any kind of fish or animal ( protein)
KR100747481B1 (en) Cracker and method for producing thereof
Kurve et al. The effect of feeding native warm season grasses in the stocker phase on the carcass quality, meat quality, and sensory attributes of beef loin steaks from grain-finished steers
CN111972494A (en) Sports nutritional milk powder and preparation method thereof
KR102631920B1 (en) A food composition comprising Neomysis awatschensis oil for anti-obesity
Kim et al. Influence of supplemental Schisandra chinensis powder on growth performance, serum cholesterol, and meat quality of broilers
Kumar et al. Selected fruit pomaces: nutritional profile, health benefits, and applications in functional foods and feeds
Sanwo et al. Meat quality and lipid profile of broiler chickens fed diets containing turmeric (Curcuma longa) powder and cayenne pepper (Capsicum frutescens) powder as antioxidants
CN114532503B (en) Red apple and cherry plum composition and application thereof in reducing blood fat
Mahmoud et al. Egyptian “Ful Medames” Mitigates Metabolic Syndrome-Associated Inflammation through Regulation of Resistin, Leptin and Adipokine mRNA Expression in Wistar Rats
KR101165933B1 (en) Feed composition for pig breeding comprising cinnammons
KR20210014272A (en) Functional beverage composition for companion animal
KR20200120549A (en) Oral composition for reducing body weight or body fat comprising Artemisia dracunculus and Taraxacum officinale
KR101038716B1 (en) Boiled fish paste made from Misgurnus mizolepis
JP2000253851A (en) Highly functional food
CN107396970A (en) A kind of production method of the Yoghourt rich in chlorella promotion growth factor
JPH08242812A (en) Functional food
KR101038715B1 (en) Boiled fish paste made from Misgurnus mizolepis
TW200417366A (en) Remedy

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right